Archive · Ars Technica
To keep drug prices high, pharma has been piling up the patents
Add-on patents have increased drug patent periods from two years to over six.
ZAZTEK archives the headline, summary and publication date so the story stays findable. The full article remains the publisher's. Read it at Ars Technica →